Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 164.695
-0.372 %
$ 8.42 B
Market Cap
823.47
P/E
CRL - TOTAL EQUITY
Total Equity CRL - Charles River Laboratories International, Inc.
3.5 B
LAST VALUE
7.63%
2 YEAR CAGR
16.02%
5 YEAR CAGR
17.40%
10 YEAR CAGR